Jazz Pharmaceuticals
JAZZ
#2195
Rank
C$9.99 B
Marketcap
$165.33
Share price
6.75%
Change (1 day)
-10.17%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$1.97

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.96. In 2022 the company made an earnings per share (EPS) of -$4.91 an increase over its 2021 EPS that were of -$7.47.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.97-59.84%
2022-$4.91-34.2%
2021-$7.47-224.83%
2020$5.98-53.25%
2019$12.8023.59%
2018$10.36-8.24%
2017$11.2923.74%
2016$9.1222.12%
2015$7.47478.49%
2014$1.29-74.93%
2013$5.15-27.11%
2012$7.0769.1%
2011$4.18245.98%
2010$1.21-462.5%
2009-$0.33-96.7%
2008-$10.11-27.04%
2007-$13.8565.47%
2006-$8.37-4.59%
2005-$8.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.58 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$11.51-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.19-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$2.78 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel